Literature DB >> 22733390

Addenbrooke's Cognitive Examination-Revised for mild cognitive impairment in Parkinson's disease.

Peter McColgan1, Jonathan R Evans, David P Breen, Sarah L Mason, Roger A Barker, Caroline H Williams-Gray.   

Abstract

INTRODUCTION: Cognitive impairment is common in Parkinson's disease (PD), even in the early stages, and appropriate screening tools are needed.
METHODS: We investigated the utility of the Addenbrooke's Cognitive Examination-Revised for detecting mild cognitive impairment (MCI) in PD in an incident population-representative cohort (n = 132) and investigated the relationship between performance on this instrument and behavior and quality of life (n = 219).
RESULTS: Twenty-two percent met criteria for MCI. Receiver operating curve analysis revealed an area under the curve of 0.81. A cutoff <89 gave a sensitivity of 69% and specificity of 84%. Scores on this instrument were highly correlated with the Parkinson's Disease Cognitive Rating Scale, and there were significant correlations with the Cambridge Behavioral Inventory-Revised and Parkinson's Disease Questionnaire 39.
CONCLUSION: This instrument is a useful screening tool for PD-MCI, and poor performance is significantly related to impaired behavior and quality of life.
Copyright © 2012 Movement Disorder Society.

Entities:  

Mesh:

Year:  2012        PMID: 22733390     DOI: 10.1002/mds.25084

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

1.  Distinct manifestation of cognitive deficits associate with different resting-state network disruptions in non-demented patients with Parkinson's disease.

Authors:  Kazuya Kawabata; Hirohisa Watanabe; Kazuhiro Hara; Epifanio Bagarinao; Noritaka Yoneyama; Aya Ogura; Kazunori Imai; Michihito Masuda; Takamasa Yokoi; Reiko Ohdake; Yasuhiro Tanaka; Takashi Tsuboi; Tomohiko Nakamura; Masaaki Hirayama; Mizuki Ito; Naoki Atsuta; Satoshi Maesawa; Shinji Naganawa; Masahisa Katsuno; Gen Sobue
Journal:  J Neurol       Date:  2018-02-01       Impact factor: 4.849

2.  The cognitive side of essential tremor: what are the therapeutic implications?

Authors:  Sarah C Janicki; Stephanie Cosentino; Elan D Louis
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

3.  Screening Mild and Major Neurocognitive Disorders in Parkinson's Disease.

Authors:  Tivadar Lucza; Kázmér Karádi; János Kállai; Rita Weintraut; József Janszky; Attila Makkos; Sámuel Komoly; Norbert Kovács
Journal:  Behav Neurol       Date:  2015-05-19       Impact factor: 3.342

4.  Addenbrooke's Cognitive Examination and Individual Domain Cut-Off Scores for Discriminating between Different Cognitive Subtypes of Parkinson's Disease.

Authors:  Dagmar Berankova; Eva Janousova; Martina Mrackova; Ilona Eliasova; Milena Kostalova; Svetlana Skutilova; Irena Rektorova
Journal:  Parkinsons Dis       Date:  2015-08-17

5.  Cerebellar integrity in the amyotrophic lateral sclerosis-frontotemporal dementia continuum.

Authors:  Rachel H Tan; Emma Devenney; Carol Dobson-Stone; John B Kwok; John R Hodges; Matthew C Kiernan; Glenda M Halliday; Michael Hornberger
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

6.  Combining perceptual regulation and exergaming for exercise prescription in low-active adults with and without cognitive impairment.

Authors:  Liam McAuliffe; Gaynor C Parfitt; Roger G Eston; Caitlin Gray; Hannah A D Keage; Ashleigh E Smith
Journal:  BMC Sports Sci Med Rehabil       Date:  2018-01-30

7.  Severe hyposmia and aberrant functional connectivity in cognitively normal Parkinson's disease.

Authors:  Noritaka Yoneyama; Hirohisa Watanabe; Kazuya Kawabata; Epifanio Bagarinao; Kazuhiro Hara; Takashi Tsuboi; Yasuhiro Tanaka; Reiko Ohdake; Kazunori Imai; Michihito Masuda; Tatsuya Hattori; Mizuki Ito; Naoki Atsuta; Tomohiko Nakamura; Masaaki Hirayama; Satoshi Maesawa; Masahisa Katsuno; Gen Sobue
Journal:  PLoS One       Date:  2018-01-05       Impact factor: 3.240

8.  The Addenbrooke's Cognitive Examination for the differential diagnosis and longitudinal assessment of patients with parkinsonian disorders.

Authors:  Timothy Rittman; Boyd C Ghosh; Peter McColgan; David P Breen; Jonathan Evans; Caroline H Williams-Gray; Roger A Barker; James B Rowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-01-08       Impact factor: 10.154

9.  Grey matter changes in cognitively impaired Parkinson's disease patients.

Authors:  Irena Rektorova; Roberta Biundo; Radek Marecek; Luca Weis; Dag Aarsland; Angelo Antonini
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  Time on timing: Dissociating premature responding from interval sensitivity in Parkinson's disease.

Authors:  Jiaxiang Zhang; Cristina Nombela; Noham Wolpe; Roger A Barker; James B Rowe
Journal:  Mov Disord       Date:  2016-04-19       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.